newsfilter
← Latest News
GlobeNewswire·

Albireo to Present New Data at the EASL International Liver Congress™ 2022

– Five abstracts accepted, long-term data confirmed durable efficacy with Bylvay™ (odevixibat), with demonstrated improvement in quality of life, growth, and sleep measurements, and hepatic biomarkers in children with all types of PFIC – Two a